UTOPIA 43 Interviews | Vol. 20 Professor Toshifumi Inada, The Institute of Medical Science, The University of Tokyo (IMSUT)
• Admiration for Researchers and My Hometown
Amami Island
Filariasis eradication and Dr. Manabu Sassa at IMSUT
IMSUT and infectious diseases
Shima-uta, Kokuto Shochu, Oshima Tsumugi
Apollo went to the moon. An era of dreams in science
Wanting to be a researcher
• The World of Molecular Biology
DNA, RNA, and amino acids that make up proteins
Deciphering codons
• UTOPIA
Ribosomes: From genetic code to protein synthesis
mRNA translation by ribosomes
Understanding the regulatory mechanisms of ribosomes and vaccine development
Joint research on malaria ribosomes
Providing basic information for vaccine design in preparation for future infectious diseases
• Funding and competitiveness
Differences in research environment with overseas researchers
Challenging research environment
• Message to Young Researchers
Aspiration
Find what you like
Research is interesting
What is talent?
Luck, timing
The joy of solving questions
9:30 meeting
Produced by Imagine inc.
------------------
The University of Tokyo Pandemic Preparedness, Infection, and Advanced Research Center (UTOPIA) was established on 18 October 2022, as the third research organization of the University of Tokyo Institutes for Advanced Study (UTIAS).
With a mission to protect people from infectious diseases and pandemics, UTOPIA brings together top researchers, transcending disciplinary boundaries, to advance infectious disease prevention and vaccine development.
In addition to experts in the fields of infectious diseases, immunology, and vaccines, UTOPIA gathers researchers from diverse fields such as AI, structural biology, social sciences, and others who have not previously been involved in infectious disease research. We also establish collaborative networks with international institutions, fostering a global cooperation framework.
By directly connecting academia, industry, and clinical settings, we aim to establish a robust infrastructure for the rapid delivery of effective and safe vaccines and therapeutics in response to emerging pandemics.